Relationship between model for end-stage liver disease score and left ventricular function in patients with end-stage liver disease

BackgroundDecreased cardiac contractility has been observed in cirrhosis, suggesting a latent cardiomyopathy in these patients. This study was designed to evaluate left ventricular structure and function in patients with end-stage liver disease by the model for end-stage liver disease (MELD) scoring system.MethodsWe recruited 82 patients (72 male, 10 female; mean age 50.3±8.9 years) with end-stage liver disease who underwent orthotopic liver transplantation between January 2002 and May 2008. Seventy-eight patients had cirrhosis and 4 had primary liver cancer. Patients were categorized into three groups on the basis of MELD score: ≤9 (27 patients, 33%); 10–19 (40, 49%); and ≥=20 (15, 18%). The relationship between MELD score and cardiac structure and function was determined. Preoperative assessments of blood biochemistry, blood coagulation, serum virology, echocardiography and electrocardiography were performed.ResultsMELD score was positively correlated with enlarged left atrial diameter, increased interventricular septum thickness (IVST), increased aortic flow, corrected QT interval (QTc) extension and cardiac Output (P= 0.033, 0.002, 0.000, 0.000 and 0.009, respectively). International normalized ratio also had a correlation with the above parameters and enlarged left ventricular end-diastolic diameter (P=0.043, 0.010, 0.000, 0.001, 0.016 and 0.008, respectively). Serum creatinine was positively correlated with IVST (r= 0.257, P= 0.020), but negatively correlated with early maximal ventricular filling velocity/late diastolic or atrial velocity ratio (r=−0.300, P= 0.006). A difference of QTc >440 ms among the three groups was statistically significant (χ2 = 9.791, P=0.007).ConclusionsAbnormalities in cardiac structure and function are common in patients with end-stage liver disease. MELD score is a practically useful approach for the assessment of cardiac function in such patients.